402 related articles for article (PubMed ID: 25145522)
1. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
[TBL] [Abstract][Full Text] [Related]
2. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
[No Abstract] [Full Text] [Related]
3. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
4. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ
JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150
[TBL] [Abstract][Full Text] [Related]
5. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
6. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
[TBL] [Abstract][Full Text] [Related]
7. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
[TBL] [Abstract][Full Text] [Related]
8. Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Zineh I; Cooper-Dehoff RM; Wessel TR; Arant CB; Sleight P; Geiser EA; Pepine CJ
Clin Cardiol; 2005 Jul; 28(7):321-8. PubMed ID: 16075824
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
[TBL] [Abstract][Full Text] [Related]
10. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ;
Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247
[TBL] [Abstract][Full Text] [Related]
11. Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Coca A; Messerli FH; Benetos A; Zhou Q; Champion A; Cooper-DeHoff RM; Pepine CJ
Stroke; 2008 Feb; 39(2):343-8. PubMed ID: 18162623
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
13. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
14. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
15. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
16. Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
Smith SM; Gong Y; Handberg E; Messerli FH; Bakris GL; Ahmed A; Bavry AA; Pepine CJ; Cooper-Dehoff RM
J Hypertens; 2014 Mar; 32(3):635-43. PubMed ID: 24299915
[TBL] [Abstract][Full Text] [Related]
17. INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Cooper-DeHoff RM; Handberg EM; Mancia G; Zhou Q; Champion A; Legler UF; Pepine CJ
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1329-40. PubMed ID: 19900016
[TBL] [Abstract][Full Text] [Related]
18. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ
PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002
[TBL] [Abstract][Full Text] [Related]
19. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ
JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047
[TBL] [Abstract][Full Text] [Related]
20. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
